You are here: Industry Insights > Canada

News List

Canada to procure GSK’s Covid-19 antibody therapy doses Pharmaceutical-Technology
January 07, 2022
In October last year, GSK signed purchase agreement with Canada to supply 10,000 doses of Sotrovimab.
Celltrion gets priority review in Canada for Covid-19 drug regdanvimab pharmaceutical-technology
August 03, 2021
Health Canada has granted priority review to Celltrion Healthcare’s experimental monoclonal antibody, regdanvimab (CT-P59), for the treatment of Covid-19.
Ocugen seeks approval for Covaxin in Canada expresspharma
July 19, 2021
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said.
Diabetes treatment pump trial begins in Canada europeanpharmaceuticalreview
July 06, 2021
A Phase I trial evaluating Adocia’s BioChaperone® Lispro Pramlintide formulation for insulin pump delivery in type 1 diabetics has begun.
AbCellera to Build Antibody Manufacturing Facility in Canada contractpharma
June 24, 2021
AbCellera has unveiled plans for the construction of a Good Manufacturing Practices (GMP) manufacturing facility in Vancouver for the production of therapeutic antibodies, which will be the first of its kind in Canada.
Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada expresspharma
June 09, 2021
Ocugen has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in Canada.
Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada expresspharma
June 04, 2021
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada.
Vivimed exports its first shipment, Famotidine tablets, to Canada expresspharma
May 25, 2021
Vivimed Labs, a niche speciality chemicals and pharma company, announced the export of its first shipment to Canada – Famotidine tablets 40 mg and 20 mg manufactured in its Vivimed Hyderabad site which is approved by Health CANADA.
Resilience Bolsters Canadian Biomanufacturing Site contractpharma
May 24, 2021
National Resilience, Inc., said that the Government of Canada will invest $163.8 million, through the Strategic Innovation Fund, in the company’s Ontario-based subsidiary Resilience Biotechnologies Inc. (RBI) to modernize and expand production capacity.
Sanofi to Build New $700M Flu Vaccine Facility in Canada contractpharma
April 06, 2021
Sanofi has unveiled an investment of more than €600 million (~$707mn) in a new vaccine manufacturing facility at its existing site in Toronto, Canada.

Previous page 1 2 3 4 Next page